enfortumab - Robuta Search

https://www.cancer.gov/news-events/cancer-currents-blog/2020/enfortumab-vedotin-bladder-cancer-fda-approval Enfortumab Vedotin Approved for Recurrent Bladder Cancer - NCI Enfortumab vedotin-ejfv (Padcev) has been approved for people with advanced bladder cancer. FDA granted the drug accelerated approval for cancers that have... enfortumab vedotin bladder cancer approved recurrent nci https://myhealth.alberta.ca/health/medications/Pages/conditions.aspx?hwid=fdb2155 Enfortumab Vedotin - Injection enfortumab vedotin injection https://pubmed.ncbi.nlm.nih.gov/38446675/?dopt=Abstract Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer Treatment with enfortumab vedotin and pembrolizumab resulted in significantly better outcomes than chemotherapy in patients with untreated locally advanced or... enfortumab vedotin pembrolizumab untreated advanced cancer https://pubmed.ncbi.nlm.nih.gov/41707170/ Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer Perioperative enfortumab vedotin plus pembrolizumab and surgery led to significantly better event-free and overall survival outcomes and a greater percentage... enfortumab vedotin perioperative pembrolizumab bladder cancer https://adisinsight.springer.com/drugsafety/803588762?error=cookies_not_supported&code=774921fe-83eb-4c83-b548-4f3bc8721bdc Enfortumab-vedotin/pembrolizumab - AdisInsight In a case series, three men aged 65-77 years were described, who developed cutaneous drug eruption and hypersensitivity reaction during treatment with enfortumab vedotin pembrolizumab adisinsight https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-enfortumab-vedotin-ejfv-pembrolizumab-locally-advanced-or-metastatic-urothelial-cancer?s=09 FDA approves enfortumab vedotin-ejfv with pembrolizumab for locally advanced or metastatic... On December 15, 2023, the Food and Drug Administration (FDA) approved enfortumab vedotin-ejfv (Padcev, Astellas Pharma) in combination with pembrolizumab... fda approves enfortumab vedotin https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/innovation-at-the-james/clinical-trials/find-a-clinical-trial/phase-ib-trial-of-erdafitinib-combined-with Phase Ib Trial of Erdafitinib Combined with Enfortumab Vedotin Following Platinum and PD1/L1... Phase Ib Trial of Erdafitinib Combined with Enfortumab Vedotin Following Platinum and PD1/L1 Inhibitors for Metastatic Urothelial Carcinoma with FGFR2/3... https://pubmed.ncbi.nlm.nih.gov/38418804/?dopt=Abstract Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients... Our results indicated the importance of focusing on enfortumab vedotin-induced neuropathy of the sural nerve to maximize efficacy and improve safety. peripheral neuropathy enfortumab vedotin nerve electrophysiological https://pubmed.ncbi.nlm.nih.gov/33577729/?dopt=Abstract Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma Enfortumab vedotin significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma... enfortumab vedotin previously treated advanced carcinoma https://adisinsight.springer.com/trials/700385369?error=cookies_not_supported&code=c7b3be87-bc17-4c6e-a3ef-94e0ab97d01d Open-Label Phase II Trial of Enfortumab Vedotin in Recurrent or Persistent Endometrial Carcinoma -... This study is testing a drug called enfortumab vedotin in up to 12 patients with advanced endometrial (uterine) cancer that has worsened after previous https://ce.massmed.nejm.org/nejm-weekly-cme/content/perioperative-enfortumab-vedotin-and-pembrolizumab-bladder-cancer Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer | MMS/NEJM Continuing... enfortumab vedotin bladder cancer perioperative pembrolizumab https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/innovation-at-the-james/clinical-trials/find-a-clinical-trial/a-study-of-intravesical-enfortumab-vedotin-for A Study of Intravesical Enfortumab Vedotin for Treatment of Patients with Non-Muscle Invasive... A Study of Intravesical Enfortumab Vedotin for Treatment of Patients with Non-Muscle Invasive Bladder Cancer (NMIBC) https://researchfestival.nih.gov/2024/posters/study-mechanisms-resistance-antibody-drug-conjugate-enfortumab-vedotin Study of the mechanisms of resistance to the Antibody-drug conjugate Enfortumab Vedotin in... of the https://adisinsight.springer.com/trials/700391518?error=cookies_not_supported&code=20bcb195-6cea-4f04-93c2-7a99c3c2d9e1 An Open-label, Single-Arm, Phase 2 Study to Evaluate Enfortumab Vedotin Plus Pembrolizumab for... The main aims of this study are to check how many people continue to respond well to enfortumab vedotin with pembrolizumab and how many people have their